ICR Consilium is a prominent player in strategic healthcare communications and investor relations operating across Europe and the U.S. Founded in 2013, the company serves as a trusted advisor to healthcare organizations, senior decision makers, and executives, offering strategic counsel on crucial communication programs and stakeholder challenges. With headquarters in the United Kingdom and offices in London and New York, Consilium's highly skilled team possesses deep expertise across various segments of the global healthcare sector, gained through extensive experience in representing renowned international clients, including the Fortune 500, FTSE 100, FTSEurofirst 300, and FTSE 250, along with specialized reputation management projects. Despite lacking recent investment information, ICR Consilium's track record and industry leadership position it as an appealing prospect for venture capital consideration.
There is no investment information
No recent news or press coverage available for ICR Healthcare (Europe).